Related Experiment Videos
Motor depression: a new role for D1 receptors?
C J Chandler1, W Wohab, B S Starr
1School of Health and Human Sciences, Hatfield Polytechnic, Hertfordshire, U.K.
Neuroscience
|January 1, 1990
Summary
This study characterized a new dopamine D1 receptor agonist, CY 208-243, and found it selectively activates D1 receptors in vivo. D1 agonist effects were modified by D2 antagonists, leading to immobility, suggesting complex receptor interactions.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Dopamine receptors, particularly D1 and D2 subtypes, play crucial roles in regulating motor behavior and other functions.
- Understanding the specific roles and interactions of these receptors is essential for developing effective therapeutic strategies for neurological and psychiatric disorders.
Purpose of the Study:
- To characterize the behavioral profile of a novel dopamine D1 receptor agonist, CY 208-243, for its utility as an in vivo research tool.
- To investigate the modulatory effects of D2 receptor antagonists on the behavioral actions of D1 agonists.
Main Methods:
- Utilized mice to assess the in vivo behavioral effects of CY 208-243 and SKF 38393 (D1 agonists) and metoclopramide and sulpiride (D2 antagonists).
- Administered varying doses of compounds and observed behaviors such as locomotion, rearing, grooming, and orofacial activities in both habituated and non-habituated conditions.
- Analyzed drug interactions, including synergistic effects leading to immobility and the impact on other species-typical behaviors.
Main Results:
- CY 208-243 demonstrated selective D1 receptor agonism in vivo, inducing behaviors like locomotion and grooming in habituated mice, which were blocked by a D1 antagonist.
- Co-administration of D2 antagonists (metoclopramide, sulpiride) with D1 agonists (CY 208-243, SKF 38393) resulted in synergistic induction of prolonged immobility.
- The observed hypokinesia was not attributable to increased behavioral competition from other activities like grooming, as these were differentially affected by the D2 antagonists.
Conclusions:
- CY 208-243 is a valuable selective D1 receptor agonist for in vivo research.
- D1 and D2 receptors appear to interact in a complex manner to regulate motor behavior, with D2 receptor blockade potentiating D1 agonist-induced hypokinesia.
- The findings suggest that exploratory behavior may be under the control of D1 receptors coupled to functionally opposing postsynaptic D2 receptors.